Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss of $0.68
Tweet
Share
E-mailGet Alerts RAPP Hot Sheet
Join SI Premium – FREE
Rapport Therapeutics, Inc. (NASDAQ: RAPP) reported Q1 EPS of ($0.68).
For earnings history and earnings-related data on Rapport Therapeutics, Inc. (RAPP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Argus Upgrades Moderna (MRNA) to Buy
- Marvell (MRVL) Reiterated at Buy by Stifel on July Quarter Beat
- PagerDuty, Inc. (PD) Tops Q2 EPS by 1c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
